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Abstract
Background: Renal involvement in patients with chronic hepatitis C virus infection has been
suggested to be due to a variety of immunological processes. However, the precise mechanism by
which the kidneys are damaged in these patients is still unclear.
Case presentation: A 66 year old man presented with the sudden onset of autoimmune
hemolytic anemia. Concomitant with a worsening of hemolysis, his initially mild proteinuria and
hemoglobinuria progressed. On admission, laboratory tests revealed that he was positive for
hepatitis C virus in his blood, though his liver function tests were all normal. The patient displayed
cryoglobulinemia and hypocomplementemia with cold activation, and exhibited a biological false
positive of syphilic test. Renal biopsy specimens showed signs of immune complex type
nephropathy with hemosiderin deposition in the tubular epithelial cells.
Conclusions: The renal histological findings in this case are consistent with the deposition of
immune complexes and hemolytic products, which might have occurred as a result of the patient's
underlying autoimmune imbalance, autoimmune hemolytic anemia, and chronic hepatitis C virus
infection.
Background
Extra-hepatic manifestations of hepatitis C virus (HCV)
infection are diverse and appear during late middle age
[1–3]. Among these, glomerulonephritis, arthritis, dermal
vasculitis and sialadenitis are thought to develop as a
result of the deposition of immune complexes (IC). It is
generally accepted that B-cells infected with HCV clonally
expand and produce autoantibodies [4,5]. When antigen-
bound, these autoantibodies, along with anti-HCV anti-
bodies that target viral epitopes on the surface of cells are
known to circulate as IC. These IC may participate in the
pathogenesis of HCV-associated glomerulonephritis,
though it has been difficult to detect these IC clinically.
While immunosuppressive agents have been used success-
fully to diminish the production of autoantibodies, such
a strategy is contraindicated in HCV patients since it
would lead to an increase in viral replication.
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Table 1: Past laboratory findings before admission
date 1998/ 1999/ 2000/ 2001/
3/27 3/4 3/24 7/21 9/11 12/18 1/30 2/7 normal range
RBC (/µl) 525 528 334 272 236 213 226 225 (374–502)
Hb (g/dl) 16.9 16.7 12.3 10.2 9.5 8.5 9.3 8.1 (11.1–15.3)
Htc (%) 49.6 49.5 34.5 28.8 26.2 24.1 25.6 24.8 (33.2–45.3)
MCV (fl) 94.5 93.8 103.3 105.9 111.0 113.1 113.3 110.2 (85.0–100.0)
MCH (pg) 32.2 31.6 36.8 37.5 40.3 39.9 41.2 36.0 (30.0–35.0)
MCHC (g/dl) 34.1 33.7 35.7 35.4 36.3 35.3 36.3 32.7 (32.0–36.0)
LDH (U/l) 371 878 1032 1348 1194 1022 1082 (220–430)
TP (g/dl) 8.1 7.6 7.1 7.4 6.2 6.3 6.3 (6.5–8.0)
Urine
P r o t e i n * +++± 2 + 3 + 3 + 3 +
(mg/dl) 73 75 78 114 480 246.8 99.8
Occult 
blood 
reaction*
±±±± 2 + 3 + 3 + 3 +
*: urine dip-stick test RBC: red blood cell, Hb: hemoglobin, Htc: hematocrit, MCV: mean corpuscular volome, MCH: mean corpuscular hemoglobin, 
MCHC: mean corpuscular hemoglobin concentration, LDH: lactate dehydogenase, TP: total protein
Table 2: Laboratory findings on admission
CBC normal range
WBC 14700 /µl 3600–9100
RBC 221 ×104/µl3 7 4 – 5 0 2
Hb 8.7 g/dl 11.1–15.3
Htc 24.7 % 33.2–45.3
MCV 112 fl 85.0–100.0
MCH 39.4 pg 30.0–35.0
MCHC 35.1 g/dl 32.0–36.0
Platelet 29.3 ×104/µl 13.0–37.0
Reticulocyte 236 ‰ 8.0–20.0
Biochemistry
T. bilirubin 2.18 mg/dl 0.30–1.20
D. bilirubin 0.69 mg/dl 0.05–0.40
AST 41 U/l 8–38
ALT 16 U/l 4–44
LDH 1044 U/l 220–430
ALP 172 U/l 117–335
ChE 219 U/l 200–450
BUN 16.0 mg/dl 8.0–19.0
Cr 1.07 mg/dl 0.80–1.30
UA 9.1 mg/dl 3.9–7.8
Na 140 mmol/l 136–148
K 4.3 mmol/l 3.6–5.0
Cl 107 mmol/l 98–109
TP 6.3 g/dl 6.5–8.0
Albumin 3.69 g/dl 3.8–5.3
T. cholesterol 161 mg/dl 130–220
Triglyceride 137 mg/dl 55–150
Syphilis
STS slide precipitation test 1+ negative
TPHA - negativeBMC Nephrology 2003, 4 http://www.biomedcentral.com/1471-2369/4/7
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Hepatitis virus
HBs Ag - negative
HCV
Ab + negative
108.5 S/CO
RNA 220 KIU/ml
genotype 1B
Immunology
IgG 1497 mg/dl 870–1700
IgA 246 mg/dl 110–410
IgM 152 mg/dl 35–220
ANA 40 dilution <80
anti-ds DNA ab <2.0 IU/ml <6.0
anti-CL-β2GPI ab 1.8 U/ml <3.5
RF <12 IU/ml <20
ASO 20 IU/ml <200
CRP <0.1 mg/dl <0.20
C3 68 mg/dl 60–140
C4 16 mg/dl 10–40
CH50 21.5 U/ml 30.0–45.0
Immune complex
C1q-assay <1.5 µg/ml <3.0
C3d-assay 8.8 µg/ml <3.0
Cryoglobulin 2+ negative
(monoclonal IgMk+polyclonal IgG)
Urinary examination
Protein 2.2 g/day 0.03–0.12
Creatine clearance 83.5 ml/min. 70.0–130.0
NAG 5.0 U/l <5.0
β2-microglobulin 137 µ g/l 5–300
Urinalysis
pH 6.0 5.0–7.0
SG 1.010 1.005–1.020
Protein 2+ -
Occult blood 3+ -
Keton - -
Sediment
RBC 5–9/HF
WBC 10–19/HF
Epithel 1–4/HF
Tubular cell 1–4/HF
Cast
Hyalin 0–1/LF
Glanular -
Oval fat body +
Table 2: Laboratory findings on admission (Continued)BMC Nephrology 2003, 4 http://www.biomedcentral.com/1471-2369/4/7
Page 4 of 7
(page number not for citation purposes)
We herein report the case of a patient with extra-hepatic
manifestations of chronic HCV infection that developed
autoimmune hemolytic anemia (AIHA) prior to evident
nephropathy.
Case presentation
A 66 year old man, with no prior history of blood transfu-
sion, drug addiction, or the acquisition of tattoos, was
diagnosed with hemolytic anemia in June of 2000. From
the time he was 50, his yearly health check-ups have
revealed faint hematuria (±) by urine dipstick testing, and
he first exhibited proteinuria when he was 60 years old
(see Table 1 for the patient's clinical history). At no time
did the patient shows signs of liver dysfunction. Two of
the patient's five brothers suffered from chronic liver dis-
ease (no further information was available) but none had
a history of anemia.
In March of 2000, the patient was diagnosed with sudden
onset anemia characterized by an increase in both mean
corpuscular volume and corpuscular hemoglobin. Result
of the Coomb's, acidified serum, sucrose hemolysis, and
cold agglutinin tests were negative. Because spherocytes
predominated in his hemogram and the results of his
erythroresistant test (Ribiere's test) were positive, he was
provisionally diagnosed as having hemolytic anemia
caused by spherocytosis. Since he was asymptomatic, he
was followed without medication.
Starting in September of 2000, the patient's hematuria
and proteinuria progressed and his hemolysis worsened.
Laboratory data began to indicate an increase in urinary
protein excretion and a lowered serum protein concentra-
tion. The patient began to experience mild pretibial
edema in March of 2001, at which time he was admitted
to our hospital and a renal biopsy performed. Hematolog-
ical tests at that time revealed the hyperchromic anemia
with a macrocytic pattern and an increased numbers of
reticulocytes. A hemogram (Figure 1) revealed the pres-
ence of unusually-shaped red blood cells (RBC), and poly-
chromatic cells and spherocytes. Ferokinetic parameters
such as Fe, unsaturated iron binding capacity (UIBC), fer-
ritin and transferrin levels were all within the normal
range. However, low levels of haptoglobin (less than 10
mg/dl; normal range = 41–341 mg/dl) and extremely high
levels of erythropoietin (114 mU/ml; normal range = 8–
36 mU/ml) were detected. Unlike his earlier results, his
direct Coombs test was now positive and binding of IgG
to the RBC surface was observed using anti-human globu-
lin monospecific antibodies. Screening for the target anti-
gen was performed using a panel of RBCs (Resolve® Panel
C, Lot no. RC246, Ortho-Clinical Diagnostics, Inc.) and
revealed aggregation with all types of RBCs. Serum
chemistry tests showed high levels of bilirubin and LDH,
presumably caused by the excessive hemolysis (Table 2).
Moderate levels of protein were found in the urine but
serum total protein levels were slightly below the normal
range. Urine dipstick testing gave a false positive result for
occult blood detection. The slide precipitation test for
syphilis also resulted in a false positive reading, though
anti-cardiolipin β2GPI antibodies were absent. Hypocom-
plementemia with cold activation was demonstrated with
the serum titer of CH50 being low though plasma titers
were recoverable (his blood was collected in EDTA-con-
taining tubes). Cryoprecipitation under cold storage
(4°C, 72 hrs) followed by immunoelectrophoresis
revealed the presence of a mixed type II cryogobulinemia.
HCV viremia was confirmed using an HCV-RNA PCR test
(genotype: 1B). Antibodies directed against HBV, HIV,
EBV, and CMV were not found. An abdominal echogram
revealed the absence of a splenomegaly and showed that
his liver was of normal size and that it had a smooth
surface.
Hemogram (May of 2001) Figure 1
Hemogram (May of 2001). Red blood cells showed anisocy-
tosis, polychromatosis, and poikilocytosis. Note the presence 
of polychromatic cells (arrow) and spherocytes (double 
arrow) in the figure.BMC Nephrology 2003, 4 http://www.biomedcentral.com/1471-2369/4/7
Page 5 of 7
(page number not for citation purposes)
Because the patient was symptom free, he was discharged
after his renal biopsy and was followed without treat-
ment. One year later, the patient had the same degree of
hemolysis (hemoglobin = 7.4 g/dl, LDH = 756 U/l, total
bilirubin = 2.7 g/dl) though his creatinine clearance had
decreased (69.5 ml/min.). However, his urinary protein
was stable (1.6 g/day) and his serum total protein recov-
ered into the normal range (7.1 g/dl). His liver function
was near normal (AST = 57 U/l, ALT = 19 U/l, albumin =
3.5 g/dl). And his level of HCV-RNA was slightly reduced
(130 KIU/ml).
Renal histology (Figure 2 and 3): Five glomeruli were vis-
ualized in the patient's biopsy specimen. One of these
glomeruli was intact while the other four, which were
mildly lobulated, appeared to show a slight increase in
mesangial cells and matrix. The glomerular basement
membrane (GBM) was partially thickened and PAS stain-
ing revealed small spikes and bubble formation. No
glomeruli had GBM cryoglobulinemic deposits. Small
fibro-cellular crescents were found in two glomeruli. The
proximal tubular epithelial cells contained numerous
hemosiderin granules.
Immunofluorescence histochemistry demonstrated the
presence of IgG in the GBM that was distributed in a
course granular pattern, as well as the presence of IgA in
the GBM and mesangial area. Staining for IgM and C3c
was faint in the mesangial area, while C3d, C4d, C1q and
fibrinogen were undetectable. Electron microscopy
revealed small subepithelial deposits and a few para-
mesangial deposits in the glomerulus.
Renal tissue (Light microscopy, PAS stain, × 200) Figure 2
Renal tissue (Light microscopy, PAS stain, × 200). The 
patient's glomeruli showed partial thickening of the GBM and 
exhibited some mesangial proliferation. Hemosiderin depos-
its were seen in the cytosol of proximal tubular epithelial 
cells (arrowhead).
Renal tissue (Immunofluorescence, × 100) Figure 3
Renal tissue (Immunofluorescence, × 100). Extensive deposi-
tion of IgG was demonstrated in the GBM using an anti-
human IgG monoclonal antibody.BMC Nephrology 2003, 4 http://www.biomedcentral.com/1471-2369/4/7
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Conclusions
In our patient, IgG autoantibody, which binds to RBCs,
was detected in our patient using the direct antiglobulin
test (Coomb's test), leading us to conclude that AIHA was
the primary pathogenic mechanism that resulted in his
hemolysis. Since his serum reacted with the full panel of
RBCs tested, his autoantibodies probably recognized a
common RBC surface antigen. Recent studies which sug-
gest that the possible target antigens in AIHA are band 3
or 4.1 peptides, Rh, or glycophorin A, all of which are
expressed on RBCs [6–8]. Our patient had not been
treated with any antiviral drugs, such as ribavirin®, which
have been shown to induce hemolytic anemia by a mech-
anism involving the oxidation-induced aggregation of
band 3, leading to the binding of autologous anti-band 3
antibodies (natural antibody); when activated by
complement, these antibodies induce intra- or extra-cap-
illary hemolysis [9]. As a matter of course, ribavirin® was
contraindicated in our case. In any event, a similar hemo-
lytic mechanism might have resulted in this patient's pro-
duction of circulating immune complex and free iron
which lodged into his kidney.
HCV-associated glomerulonephritis is characterized by
two types of histological changes i.e., membranoprolifer-
ative glomerulonephritis and membranous nephropathy
(MN) [10,11]. Since the deposition of immunoglobulin
and complement is detected on the glomeruli in this con-
dition, these histological changes are thought to be due to
immune complex disease [10–12]. In our case, prolifera-
tive changes were slight, and immunoglobulins and com-
plement breakdown products were found to be deposited
primarily in the GBM. Therefore, the primary histological
changes in our patient's kidney were classified as being of
the MN type. We speculate that glomerular deposition of
IC occurred during chronic progression of the disease
when the ratio of antigen and antibody was optimized.
There were no direct evidence of a causal relationship
between chronic HCV infection and the occurrence of
AIHA in our patient, though such a relationship has been
suggested in four published reports [13–16]. Two of four
patients that received an orthotopic liver transplant (OLT)
were reported to have developed AIHA [13,14]. Though
the pathogenesis of AIHA was not discussed in those stud-
ies, it may have been related to the strong immunosup-
pressive therapy that the post-OLT patients received.
Another reported case of AIHA was reported in a patient
who suffered from B cell chronic lymphocytic leukemia
who was being treated with intermittent chemotherapy
[15], while still another case was reported in a patient who
had a complete congenital deficiency of IgA [16]. Thus,
the immune systems of the above four patients were com-
promised prior to their development of hemolysis. What
is not known is how chronic HCV infection leads to AIHA.
The following evidence suggested that this patient's
chronic immunological imbalance was triggered by
chronic HCV infection. 1) HCV viremia was confirmed. 2)
Our patient was of late middle age and this age group was
shown to have a high frequency of extra-hepatic manifes-
tations of HCV infection [1,3]. 3) It is accepted that the
presence of cryoglobulinemia, hypocomplementemia
(cold activation), and a biological false positive on the
syphilic test are characteristic abnormalities in patients
with chronic HCV infection [1,12,17,18]. In just recently
paper, Ramos et al. reviewed highly suspected 17 cases
with HCV-related AIHA [19]. These authors suggested that
a higher prevalence of immunologic markers including
cryoglobulinemia and hypocomplementemia all support
the hypothesis that HCV-related AIHA has an autoim-
mune pathogenesis caused by chronic HCV infection.
We concluded that renal involvement in our patient post-
dated his development of AIHA, which occurred against
the backdrop of a progressive autoimmune imbalance
induced by chronic HCV infection.
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